IN VIVO Execs On The Move, June 2014
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
You may also be interested in...
Regulators in high-income countries have a responsibility to help health authorities in low- and medium- income countries develop regulatory frameworks for cell and gene therapy products to ensure these treatments are available to all, asserts the US FDA’s biologics center’s director.
Democratic lawmakers argue the Trump administration’s interpretation of how COVID-19 testing is covered by private insurers runs contrary to the Families First Act and CARES Act. They want the administration to update a FAQ sheet that eliminates certain prerequisites that would qualify patients to be reimbursed for the tests.
Angelo De Rosa, vice president of Boston Scientific's cardiac rhythm management business in Europe, the Middle East and Asia, talked to Medtech Insight about the opportunities to accelerate digital transformation in health care during the COVID-19 crisis.